Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Birnbaum

Showing results (121-130 of 232) with videos related to

Pageof 24
Sort By:
Journal of Managed Care Pharmacy : JMCP|July 7, 2005
Direct costs of opioid abuse in an insured population in the United StatesAlan G White, Howard G Birnbaum, Milena N Mareva, et al.
Progress in Brain Research|December 16, 2006
Signal transduction mechanisms in memory disordersSara C Shalin, Regula Egli, Shari G Birnbaum, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 24, 2015
Estimating the health care burden of prescription opioid abuse in five European countriesAmie Shei, Matthew Hirst, Noam Y Kirson, et al.
Diabetes Care|November 5, 2013
Burden of diabetic foot ulcers for medicare and private insurersJ Bradford Rice, Urvi Desai, Alice Kate G Cummings, et al.
Journal of Managed Care & Specialty Pharmacy|September 30, 2020
Direct Costs of Opioid Abuse in an Insured Population in the United StatesAlan G White, Howard G Birnbaum, Milena N Mareva, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2001
Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity markerD Krametter, G Niederwieser, A Berghold, et al.
Pain Medicine (Malden, Mass.)|August 1, 2012
A model to identify patients at risk for prescription opioid abuse, dependence, and misuseJ Bradford Rice, Alan G White, Howard G Birnbaum, et al.
Journal of Medical Economics|March 2, 2012
Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the USJ I Ivanova, R E Bergman, H G Birnbaum, et al.
Current Medical Research and Opinion|October 22, 2005
Economic burden and co-morbidities of atrial fibrillation in a privately insured populationEric Q Wu, Howard G Birnbaum, Milena Mareva, et al.
Lancet (London, England)|May 9, 1970
Virus-like particles and nucleoprotein-type filaments in brain tissue from two patients with Creutzfeldt-Jakob diseaseM L Vernon, L Horta-Barbosa, D A Fuccillo, et al.
Pageof 24

Showing results (121-130 of 232) with videos related to

Sort By:
Pageof 24
Journal of Managed Care Pharmacy : JMCP|July 7, 2005
Direct costs of opioid abuse in an insured population in the United StatesAlan G White, Howard G Birnbaum, Milena N Mareva, et al.
Progress in Brain Research|December 16, 2006
Signal transduction mechanisms in memory disordersSara C Shalin, Regula Egli, Shari G Birnbaum, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 24, 2015
Estimating the health care burden of prescription opioid abuse in five European countriesAmie Shei, Matthew Hirst, Noam Y Kirson, et al.
Diabetes Care|November 5, 2013
Burden of diabetic foot ulcers for medicare and private insurersJ Bradford Rice, Urvi Desai, Alice Kate G Cummings, et al.
Journal of Managed Care & Specialty Pharmacy|September 30, 2020
Direct Costs of Opioid Abuse in an Insured Population in the United StatesAlan G White, Howard G Birnbaum, Milena N Mareva, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2001
Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity markerD Krametter, G Niederwieser, A Berghold, et al.
Pain Medicine (Malden, Mass.)|August 1, 2012
A model to identify patients at risk for prescription opioid abuse, dependence, and misuseJ Bradford Rice, Alan G White, Howard G Birnbaum, et al.
Journal of Medical Economics|March 2, 2012
Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the USJ I Ivanova, R E Bergman, H G Birnbaum, et al.
Current Medical Research and Opinion|October 22, 2005
Economic burden and co-morbidities of atrial fibrillation in a privately insured populationEric Q Wu, Howard G Birnbaum, Milena Mareva, et al.
Lancet (London, England)|May 9, 1970
Virus-like particles and nucleoprotein-type filaments in brain tissue from two patients with Creutzfeldt-Jakob diseaseM L Vernon, L Horta-Barbosa, D A Fuccillo, et al.
Pageof 24